Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Century Therapeutics (IPSC) EBT Margin (2022 - 2025)

Historic EBT Margin for Century Therapeutics (IPSC) over the last 4 years, with Q1 2025 value amounting to 70.13%.

  • Century Therapeutics' EBT Margin rose 33521200.0% to 70.13% in Q1 2025 from the same period last year, while for Sep 2025 it was 21.79%, marking a year-over-year increase of 48477400.0%. This contributed to the annual value of 1893.7% for FY2024, which is 41372600.0% up from last year.
  • Century Therapeutics' EBT Margin amounted to 70.13% in Q1 2025, which was up 33521200.0% from 821.88% recorded in Q4 2024.
  • In the past 5 years, Century Therapeutics' EBT Margin registered a high of 70.13% during Q1 2025, and its lowest value of 32667.68% during Q2 2023.
  • Moreover, its 4-year median value for EBT Margin was 3544.14% (2022), whereas its average is 7414.95%.
  • Per our database at Business Quant, Century Therapeutics' EBT Margin plummeted by -304492000bps in 2023 and then skyrocketed by 286229300bps in 2024.
  • Over the past 4 years, Century Therapeutics' EBT Margin (Quarter) stood at 6074.86% in 2022, then tumbled by -147bps to 15025.0% in 2023, then surged by 95bps to 821.88% in 2024, then skyrocketed by 109bps to 70.13% in 2025.
  • Its EBT Margin was 70.13% in Q1 2025, compared to 821.88% in Q4 2024 and 3948.67% in Q3 2024.